Product Information

LUBIPROSTONE 24 MCG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.6239 per EA under NDC 31722040460. Its NADAC has been published 48 times since Sep 24, 2025.

FDA first approved this application on Jan 2, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LUBIPROSTONE 24 MCG CAPSULE

lubiprostone
$0.6239per EA

Strength

.024 mg/1

NDC

31722040460

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LUBIPROSTONE

Approval Type

Generic (ANDA)

FDA Application

ANDA218640

FDA Approved

1/2/2025

TE Code

AB

On Market Since

5/27/2025

Pharmacological Classes

Chloride Channel Activator
Chloride Channel Activators

Price Statistics

The NADAC for LUBIPROSTONE 24 MCG CAPSULE has been published 48 times since Sep 24, 2025, and over the history we have for it it has declined 24.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6239 per EA
All-time high$0.8250 (Oct 15, 2025)
All-time low$0.6239 (Aug 19, 2026)
52-week high$0.8250
52-week low$0.6239
Median price$0.7418
Average price$0.7301
Largest weekly change-5.9% (Mar 18, 2026)
Weeks tracked48
Tracking sinceSep 24, 2025

Price History

1W

-1.0%

1M

-1.0%

3M

-6.0%

6M

-15.9%

1Y

N/A

3Y

N/A

5Y

N/A

All

-24.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of LUBIPROSTONE 24 MCG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LUBIPROSTONE 24 MCG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.6239 per EA (NDC 31722040460), effective Aug 19, 2026.

How has the price of LUBIPROSTONE 24 MCG CAPSULE changed over time?

Over the history we have for it, the NADAC for LUBIPROSTONE 24 MCG CAPSULE has declined 24.4%. It has been tracked across 48 weekly CMS publications since Sep 24, 2025.

What are the highest and lowest recorded NADAC prices for LUBIPROSTONE 24 MCG CAPSULE?

Since Sep 24, 2025, the NADAC for LUBIPROSTONE 24 MCG CAPSULE has ranged from a low of $0.6239 (Aug 19, 2026) to a high of $0.8250 (Oct 15, 2025), with a median of $0.7418 per EA.

Are there cheaper alternatives to LUBIPROSTONE 24 MCG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LUBIPROSTONE 24 MCG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures LUBIPROSTONE 24 MCG CAPSULE?

LUBIPROSTONE 24 MCG CAPSULE (NDC 31722040460) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.